Latest Breaking News On - கேப்ரியல் அறிவியல் - Page 1 : comparemela.com

Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U S and a New Product for Professional and Consumer Care in Switzerland

Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U S and a New Product for Professional and Consumer Care in Switzerland
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Sonoma pharmaceuticals incGabriel scienceSystems solutionsSonoma pharmaceuticalsGenix oral hygiene rinseMedical systems solutionsOral careசோணோமா மருந்துகள் இன்க்கேப்ரியல் அறிவியல்அமைப்புகள் தீர்வுகள்சோணோமா மருந்துகள்வாய்வழி பராமரிப்பு

Sonoma Pharmaceuticals, Inc : Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U S and a New Product for Professional and Consumer Care in Switzerland

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications

United statesMark fontenotBruce thorntonEdgar sommerExchange commissionGabriel scienceSonoma pharmaceuticals incSonoma pharmaceuticalsSystems solutionsSystem solutionsGenix oral hygiene rinseMedical systems solutionsMicrodacyn oral careOrogenix oral hygiene rinseGeneral managerMedical system

Sonoma Pharmaceuticals Inc (SNOA) is on the roll with an average volume of 107 77K in the recent 3 months

Sonoma Pharmaceuticals Inc (SNOA) is on the roll with an average volume of 107 77K in the recent 3 months
investchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investchronicle.com Daily Mail and Mail on Sunday newspapers.

Warren buffettSonoma pharmaceuticals incGabriel scienceSonoma pharmaceuticals announces expanded dental care lineSystems solutionsSonoma pharmaceuticalsNew productProfessional careConsumer careGenix oral hygiene rinseMedical systems solutionsOral careStocks primedExplode theEquity ratioRaw stochastic

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2021 Financial Results | 0 Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care and dermatological conditions today announced financial results for fiscal year 2021 and the fourth quarter ended March 31, 2021. “For the past 18 months we have been restructuring the Company to cut losses while positioning it for growth,” said Amy Trombly, CEO. “Last year we consolidated all manufacturing at our factory in Mexico (June), and ended our contract with Invekra that required us to sell product with low margin (October). This year, we entered into a partnership agreement with EMC Pharma, LLC for the sale

United statesNew zealandHong kongTestsieger finanztestGabriel scienceTe arai biofarma ltdSonoma pharmaceuticals incCpharmaceuticals aktieExchange commissionSonoma pharmaceuticalsVetsynova coNasocyn nasal careOracyn oralMiddle eastQuarter ended marchLatin america

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn Technology products into the dental market and has accepted its first order. Endocyn, a Microcyn Technology product manufactured by Sonoma, is a biocompatible root canal irrigant that does not stain teeth or restorations. In a study conducted by the Departments of Endodontics and Cell Biology and Anatomy at Louisiana State University School of Dentistry published in the Journal of Endodontics, Regenerative Endo

United statesMark fontenotAmy tromblyExchange commissionSonoma pharmaceuticals incGabriel scienceLouisiana state university school of dentistrySonoma pharmaceuticalsMicrocyn technologyCell biologyLouisiana state university schoolRegenerative endodonticsPrivate securities litigation reform actஒன்றுபட்டது மாநிலங்களில்குறி ஃபாந்‌டெநட்பரிமாற்றம் தரகு